Mr. Patrick Tippoo is the chief science and innovation officer at Biovac in South Africa and is a founding member of the African Vaccine Manufacturing Initiative where he has served as executive director for more than 10 years.
Predictions for African vaccine manufacturing in 2024: The pace of progress will hinge on demand predictability, financial mobilization, and regulatory strengthening.
